Skip to content

Member

Tiemo WÖLKEN

S&D · Germany

Group
S&D
Country
Germany
Roll-call participation
72.7 %ⓘ of 2 521 roll calls in office · chamber median 90.9 % · 2026, roll calls
With majority line
96.3 %ⓘ of 1 833 votes where the group had a line · S&D median 95.8 %
More facts (5)
National party
SPD Sozialdemokratische Partei Deutschlands
In office
Since 16 Jul 2024
Against clear line
51 of 1 798 votesⓘ
Committees
ENVI, JURI (substitute), SANT
Member id
185619
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

72.7 %

1 833 of 2 521 roll calls while in office

S&D median: 90.1 % (−17.4 pts)

Chamber median: 90.9 %

With majority line ⓘ

96.3 %

1 766 of 1 833 votes where their group had a line

S&D median: 95.8 % (+0.5 pts)

Against clear line ⓘ

2.8 %

51 of 1 798 votes where their group had a clear line

44 opposite (for ↔ against), 4 abstained against the line, 3 voted for or against when the line was to abstain

Abstention ⓘ

1.0 %

18 of 1 833 votes cast

Participation 72.7 % — S&D median 90.1 %, 135 members.ⓘ
Data as a table
Participation among the 135 members of the S&D with enough votes.
FigureParticipation
Tiemo WÖLKEN72.7 %
S&D median90.1 %
Lowest in the group35.1 %
Highest in the group99.7 %
Members135
With majority line 96.3 % — S&D median 95.8 %, 135 members.ⓘ
Data as a table
With majority line among the 135 members of the S&D with enough votes.
FigureWith majority line
Tiemo WÖLKEN96.3 %
S&D median95.8 %
Lowest in the group83.7 %
Highest in the group99.5 %
Members135
  • 2026, 2 521 roll-call votes. The dots are the other members of S&D; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 620

Export

Every final roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecisionResultPositionMajority line
17 Sept 2026Deteriorating situation of media freedom and freedom of expression in Hong Kong following the recent arrest of bookseller Leticia Wong and the convictions of Lee Cheuk-yan and Chow Hang-tung Adopted 459 for, 12 against, 86 abstainedPosition: For Majority line: For
17 Sept 2026Political prisoners in Cuba, in particular the case of Félix Navarro and his daughter Saylí Navarro Adopted 374 for, 198 against, 19 abstainedPosition: Against Majority line: Against
17 Sept 2026An EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sector Adopted 514 for, 61 against, 33 abstainedPosition: For Majority line: For
17 Sept 2026Post-electoral repression in Zambia and the killing of Mutotwe Kafwaya Adopted 562 for, 1 against, 33 abstainedPosition: For Majority line: For
17 Sept 2026Impact of social media and the online environment on young people Adopted 395 for, 136 against, 80 abstainedPosition: For Majority line: For
17 Sept 2026The role of social, economic and environmental standards in safeguarding fair competition for all aquatic food products and improving food security Adopted 467 for, 92 against, 44 abstainedPosition: For Majority line: For
17 Sept 2026Evaluation of the Common Fisheries Policy and follow-up Adopted 368 for, 172 against, 69 abstainedPosition: No vote recorded Majority line: For
17 Sept 2026Narco-trafficking in Europe’s waters: protecting our borders and supporting our law enforcement officers Adopted 601 for, 4 against, 5 abstainedPosition: For Majority line: For
17 Sept 2026The recent hybrid attacks and instrumentalisation of migrants in Ceuta and the need for a coordinated response to protect EU’s external borders Adopted 339 for, 225 against, 16 abstainedPosition: Against Majority line: Against
17 Sept 2026Strengthening global health resilience in partner countries Adopted 319 for, 142 against, 19 abstainedPosition: For Majority line: For
16 Sept 2026Simplification of intra-EU transfers of defence-related products and simplification of security and defence procurement (Omnibus V) Passed 549 for, 92 against, 27 abstainedPosition: For Majority line: For
16 Sept 2026Acceleration of permit-granting for defence readiness projects (Omnibus V) Passed 540 for, 105 against, 22 abstainedPosition: For Majority line: For
16 Sept 2026Defence readiness and facilitating defence investments and conditions for the defence industry (Omnibus V) Passed 530 for, 125 against, 12 abstainedPosition: For Majority line: For
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Passed 496 for, 53 against, 125 abstainedPosition: For Majority line: For
16 Sept 2026Instrument for Nuclear Safety Cooperation 2028-2034 Passed 600 for, 21 against, 48 abstainedPosition: For Majority line: For
16 Sept 2026Nuclear decommissioning assistance programme of the Ignalina nuclear power plant in Lithuania for the period 2028-2034 Passed 625 for, 20 against, 22 abstainedPosition: For Majority line: For
16 Sept 2026EU-Switzerland Agreement on the transfer of passenger name record (PNR) data for the prevention, detection, investigation and prosecution of terrorist offences and serious crime Consent given 549 for, 75 against, 30 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026EU-UK Agreement regarding cooperation on the application of their respective competition laws Consent given 640 for, 5 against, 26 abstainedPosition: For Majority line: For
16 Sept 2026EU-Iceland Agreement on the participation of Iceland in GOVSATCOM and in the Union Secure Connectivity Programme Consent given 631 for, 7 against, 15 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026EU-Norway Agreement on the participation of Norway in GOVSATCOM and in the Union Secure Connectivity Programme Consent given 612 for, 8 against, 16 abstainedPosition: No vote recorded Majority line: For
16 Sept 2026Genetically modified soybean GMB151 x DAS-44406-6 Objection passed 442 for, 184 against, 12 abstainedPosition: For Majority line: For
16 Sept 2026Genetically modified soybean MON 94313 Objection passed 457 for, 184 against, 10 abstainedPosition: For Majority line: For
16 Sept 2026Genetically modified maize MON 87460 Objection passed 433 for, 159 against, 10 abstainedPosition: For Majority line: For
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Adopted 470 for, 129 against, 62 abstainedPosition: For Majority line: For
16 Sept 2026An EU cardiovascular diseases strategy Adopted 545 for, 47 against, 75 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Adopted 390 for, 218 against, 29 abstainedPosition: For Majority line: For
15 Sept 2026Carbon Border Adjustment Mechanism: extension of its scope to downstream goods and anti-circumvention measures Passed 464 for, 50 against, 159 abstainedPosition: For Majority line: For
15 Sept 2026Establishing the Temporary Decarbonisation Fund Passed 433 for, 97 against, 146 abstainedPosition: For Majority line: For
15 Sept 2026Market stability reserve for the EU Emissions Trading System (EU ETS): ceasing the invalidation of allowances Passed 367 for, 240 against, 59 abstainedPosition: For Majority line: For
15 Sept 2026Market stability reserve for the buildings, road transport and additional sectors Passed 467 for, 158 against, 41 abstainedPosition: For Majority line: For
15 Sept 2026Implementation into Union law of measures adopted by regional fisheries management organisations Passed 559 for, 48 against, 62 abstainedPosition: For Majority line: For
15 Sept 2026General Fisheries Commission for the Mediterranean (GFCM): fishing in the GFCM Agreement area Passed 580 for, 51 against, 39 abstainedPosition: For Majority line: For
15 Sept 2026Temporary trade-liberalisation measures applicable to Armenian products Passed 583 for, 49 against, 39 abstainedPosition: For Majority line: For
15 Sept 2026Draft amending budget No 2/2026: update of revenue (own resources) and adjustments to expenditure Passed 440 for, 127 against, 104 abstainedPosition: For Majority line: For
15 Sept 2026Findings and recommendations of the Special Committee on the European Democracy Shield Adopted 420 for, 220 against, 26 abstainedPosition: For Majority line: For
15 Sept 2026Implementation of the Council Recommendation on a Bridge to Jobs – Reinforcing the Youth Guarantee Adopted 530 for, 77 against, 61 abstainedPosition: For Majority line: For
15 Sept 2026The EU Youth Strategy 2019–2027 Adopted 477 for, 124 against, 66 abstainedPosition: For Majority line: For
15 Sept 2026Global role of the euro Adopted 405 for, 146 against, 60 abstainedPosition: For Majority line: For
9 Jul 2026Establishment of the digital euro Negotiating mandate approved 416 for, 169 against, 22 abstainedPosition: For Majority line: For
9 Jul 2026The threat of war crimes, the escalating violations of international humanitarian law and the human rights situation in El-Obeid, Sudan Adopted 476 for, 28 against, 96 abstainedPosition: For Majority line: For
9 Jul 2026Ongoing persecution of Christians in Nigeria, notably the Kawel village massacre Adopted 510 for, 1 against, 86 abstainedPosition: For Majority line: For
9 Jul 2026Feasibility of a 28th tax regime and its potential to support EU competitiveness Adopted 366 for, 192 against, 39 abstainedPosition: For Majority line: For
8 Jul 2026EU–Mexico Political, Economic and Cooperation Strategic Partnership Agreement Consent given 479 for, 119 against, 65 abstainedPosition: For Majority line: For
8 Jul 2026Protection of the environment through criminal law Consent given 499 for, 99 against, 69 abstainedPosition: For Majority line: For
8 Jul 2026EU–Mexico Interim Agreement on Trade Consent given 474 for, 131 against, 60 abstainedPosition: For Majority line: For
8 Jul 2026EU–Morocco Euro-Mediterranean Aviation Agreement: accession to the EU of Croatia (Protocol) Consent given 625 for, 16 against, 20 abstainedPosition: For Majority line: For
8 Jul 2026EU-Morocco Agreement for scientific and technological cooperation setting out the terms and conditions for the participation of Morocco in the Partnership for Research and Innovation in the Mediterranean Area (PRIMA): amendment and supplement Consent given 573 for, 35 against, 37 abstainedPosition: For Majority line: For
8 Jul 2026Trajectory to decrease the contribution of high indirect land-use change-risk biofuels, bioliquids and biomass fuels to renewable energy targets Objection passed 388 for, 248 against, 24 abstainedPosition: Against Majority line: Against
8 Jul 2026Lead in certain fishing tackle Objection failed 197 for, 455 against, 7 abstainedPosition: Against Majority line: Against
8 Jul 2026Genetically modified maize NK603 × T25 Objection passed 460 for, 189 against, 14 abstainedPosition: For Majority line: For

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 17 of 34 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within S&D

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
René REPASI S&DGermany98 % of 4 172 shared93 %
Gabriele BISCHOFF S&DGermany97 % of 4 319 shared93 %
Tobias CREMER S&DGermany97 % of 4 120 shared93 %
Jens GEIER S&DGermany97 % of 3 908 shared93 %
Katarina BARLEY S&DGermany97 % of 3 157 shared93 %
Vivien COSTANZO S&DGermany97 % of 4 360 shared93 %
Udo BULLMANN S&DGermany97 % of 3 698 shared93 %
Matthias ECKE S&DGermany97 % of 4 089 shared93 %
Birgit SIPPEL S&DGermany97 % of 3 778 shared93 %
Delara BURKHARDT S&DGermany97 % of 3 492 shared93 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Gerben-Jan GERBRANDY RenewNetherlands90 % of 4 388 shared86 %
Raquel GARCÍA HERMIDA-VAN DER WALLE RenewNetherlands89 % of 4 390 shared86 %
Martin HOJSÍK RenewSlovakia89 % of 4 146 shared86 %
Ľudovít ÓDOR RenewSlovakia89 % of 4 126 shared86 %
Yvan VEROUGSTRAETE RenewBelgium89 % of 3 653 shared86 %
Lucia YAR RenewSlovakia89 % of 4 350 shared86 %
Charles GOERENS RenewLuxembourg89 % of 4 074 shared86 %
Michal WIEZIK RenewSlovakia89 % of 4 083 shared86 %
Jana TOOM RenewEstonia89 % of 3 745 shared86 %
Dainius ŽALIMAS RenewLithuania89 % of 4 091 shared86 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on the Environment, Climate and Food SafetyENVI CommitteeMember20 Jan 2025now
Committee on Legal AffairsJURI CommitteeSubstitute19 Jul 2024now
Committee on Public HealthSANT CommitteeMember23 Jan 2025now
Delegation for relations with South AfricaD-ZA DelegationMember19 Sept 2024now
Intergroup on Trade UnionsIG10-24 Intergroup / working groupMember31 Jan 2025now
Intergroup on the Welfare and Conservation of AnimalsIG10-27 Intergroup / working groupMember8 Jan 2025now
Committee on the Environment, Public Health and Food SafetyENVI CommitteeMember19 Jul 202419 Jan 2025
Subcommittee on Public HealthSANT SubcommitteeMember19 Jul 202419 Jan 2025

Show all 8 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
European Union regulatory fitness and subsidiarity and proportionality – report on Better Law-Making covering 2025 and 2026Shadow rapporteurJURI7 Jul 2026
Replacing S&D shadow rapporteur for the Amending Regulations (EU) 2024/1689 and (EU) 2018/1139 as regards the simplification of the implementation of harmonised rules on artificial intelligence (Digital Omnibus on AI)Trilogue negotiator6 May 2026
Clean corporate vehiclesRapporteurENVI21 Apr 2026
Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex IShadow rapporteurSANT15 Apr 2026
Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act)Opinion rapporteurJURI10 Mar 2026
European Union regulatory fitness and subsidiarity and proportionality – report on Better Law-Making covering 2023 and 2024Shadow rapporteurJURI17 Nov 2025
Amending Directives 2000/14/EC, 2011/65/EU, 2013/53/EU, 2014/29/EU, 2014/30/EU, 2014/31/EU, 2014/32/EU, 2014/33/EU, 2014/34/EU, 2014/35/EU, 2014/53/EU, 2014/68/EU and 2014/90/EU of the European Parliament and of the Council as regards digitalisation and common specificationsShadow rapporteur for an opinionENVI21 Oct 2025
Amending Regulations (EU) No 765/2008, (EU) 2016/424, (EU) 2016/425, (EU) 2016/426, (EU) 2023/1230, (EU) 2023/1542 and (EU) 2024/1781 as regards digitalisation and common specificationsShadow rapporteur for an opinionENVI21 Oct 2025
Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795Shadow rapporteur for an opinionENVI23 Jun 2025
Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795Shadow rapporteurSANT21 May 2025

Show all 23 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

26 contributions recorded; 2 on behalf of their group; 35 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
DateDebateKindVerbatim
16 Sept 2026Stop gold-plating, relieve SMEs: Member States must implement EU legislation without adding extra bureaucracy (topical debate) Speech · 1 minRead
8 Jul 2026EU’s response and preparedness to protect people against recurring heatwaves and upcoming wildfires (debate) Speech · 1 minRead
21 May 2026Need for an adaptation of the EU legal framework on sustainable biofuels (debate) Speech · 1 minRead
21 May 2026European Citizens’ Initiative ‘Stop destroying videogames’ (debate) Speech · 1 minRead
21 May 2026European Citizens’ Initiative ‘Stop destroying videogames’ (debate) Speech · 1 minRead
21 May 2026European Citizens’ Initiative ‘Stop destroying videogames’ (debate) Speech · 1 minRead
20 May 2026Reviewing the ETS system to support European competitiveness (topical debate) Speech · 2 minRead
28 Apr 2026Enforcement of the Digital Markets Act (debate) Speech · 1 minRead
28 Apr 2026Presentation of the Better Regulation and Enforcement Communication (debate) on behalf of S&DSpeech · 1 minRead
8 Oct 2025Europe’s automotive future – reversing the ban on the sale of combustion cars in the EU (topical debate) Speech · 2 minRead

Show all 26 recent contributions

Questions and motions, 20

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
14 Sept 2026Exclusion of purchases of Russian sable pelts from EU sanctions E-10-2026-003651Written questionwith 13 co-authorsNot yet answered
1 Jul 2026PROPOSAL FOR A DECISION requesting the Authority for European Political Parties and European Political Foundations to verify whether Europe of Sovereign Nations Party complies with the conditions laid down in Article 3(1), points (d) and (e), of Regulation (EU, Euratom) 2025/2445 B-10-2026-0338Motion for a resolutionwith 246 co-authors—
10 Jun 2026Potential conflict of interest in the appointment of the Special Envoy for Industrial AI P-10-2026-002401Priority written questionwith 37 co-authors13 Aug 2026
19 May 2026Biofuels and e-fuels in road transport E-10-2026-002077Written questionwith 5 co-authors14 Jul 2026
15 Apr 2026Cali fund – follow up from COP16 UN Convention on Biodiversity O-10-2026-000017Oral questionwith 2 co-authorsNot yet answered
23 Mar 2026MOTION FOR A RESOLUTION on the Commission delegated regulation of 3 February 2026 supplementing Regulation (EU) 2024/3012 of the European Parliament and of the Council by establishing the certification methodologies for permanent carbon removals activities B-10-2026-0181Motion for a resolutionwith 2 co-authors—
20 Feb 202612 months extension of the Supplementary Protection Certificate within the proposed European Biotech Act P-10-2026-000725Priority written question13 Apr 2026
3 Feb 2026Ensuring patient safety for all Europeans: the need to establish a warning system for disqualified medical professionals E-10-2026-000428Written questionwith 24 co-authors27 Mar 2026
5 Nov 2025Better regulation P-10-2025-004346Priority written question6 Jan 2026
5 Sept 2025A standardised LEZ sticker for cars E-10-2025-003461Written questionwith 3 co-authors8 Dec 2025

Show all 20 questions and motions

Amendments tabled in committee, 75

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791887 SANT51
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791891 SANT85
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791890 SANT66
15 Jul 2026General budget of the European Union for the financial year 2027 - all sections SANT-AM-789117 SANT18
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790937 CJ5320
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790934 CJ5332
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790939 CJ5313
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790933 CJ5335
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790953 CJ5324
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790005 CJ5310

Show all 75 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Germany National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Tiemo WÖLKEN”. Member record. memberId 185619. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/185619?period=2026 (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/185619. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/185619?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-185619,
  author = {{EU Parl Watch Research}},
  title = {{Tiemo WÖLKEN}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/185619?period=2026}},
  url = {https://news.eu-parl.st-solutions.dev/members/185619?period=2026},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 185619. Official source: https://www.europarl.europa.eu/meps/en/185619. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}